GB

Gajanand Baburao Chame

Active Director Director DIN 09040997
DIN 09040997 First appointment Jan 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Gajanand Baburao Chame

Data last updated:

Gajanand Baburao Chame is a Director at Spia Pharmaceutical Private Limited (since 2021). The company operates in Pharma.

DIN 09040997
Primary Designation Director
Industry Pharma
First Appointment 23 Jan 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Spia Pharmaceutical Private Limited U24290MH2021PTC354027
Director23 Jan 20212021Active

Board colleagues of Gajanand Baburao Chame

NameDINCompanyDesignation
Supriya Ramesh Chevale09040998Spia Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Spia Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Gajanand Baburao Chame

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gajanand Baburao Chame

Gajanand Baburao Chame currently holds 1 directorship: Spia Pharmaceutical Private Limited (Director, since 23 Jan 2021).

Gajanand Baburao Chame was first appointed on 23 Jan 2021 as Director at Spia Pharmaceutical Private Limited.

The current boards of Gajanand Baburao Chame's companies include Supriya Ramesh Chevale (Spia Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available